OncoCyte (LTS:0KCC) Days Sales Outstanding : 343.79 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OncoCyte Days Sales Outstanding?

OncoCyte's average Accounts Receivable for the three months ended in Dec. 2023 was $1.18 Mil. OncoCyte's Revenue for the three months ended in Dec. 2023 was $0.31 Mil. Hence, OncoCyte's Days Sales Outstanding for the three months ended in Dec. 2023 was 343.79.

The historical rank and industry rank for OncoCyte's Days Sales Outstanding or its related term are showing as below:

LTS:0KCC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.93 Med: 219.62 Max: 657.04
Current: 388.31

During the past 11 years, OncoCyte's highest Days Sales Outstanding was 657.04. The lowest was 60.93. And the median was 219.62.

LTS:0KCC's Days Sales Outstanding is ranked worse than
94.67% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.24 vs LTS:0KCC: 388.31

OncoCyte's Days Sales Outstanding declined from Dec. 2022 (666.39) to Dec. 2023 (343.79).

OncoCyte Days Sales Outstanding Historical Data

The historical data trend for OncoCyte's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoCyte Days Sales Outstanding Chart

OncoCyte Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

60.93

136.17

657.04

303.07

OncoCyte Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															666.39	601.11	356.43	382.65	343.79

Competitive Comparison of OncoCyte's Days Sales Outstanding

For the Diagnostics & Research subindustry, OncoCyte's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoCyte's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OncoCyte's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where OncoCyte's Days Sales Outstanding falls into.

OncoCyte Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

OncoCyte's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2.012	+	0.484)	/	2 )	/	1.503	*	365
=	1.248					/	1.503	*	365
=	303.07

OncoCyte's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.882	+	0.484)	/	2 )	/	0.314	*	365 / 4
=	1.183					/	0.314	*	365 / 4
=	343.79

OncoCyte (LTS:0KCC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

OncoCyte Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of OncoCyte's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoCyte (LTS:0KCC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OncoCyte Corp (LTS:0KCC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

OCX:USA

Address

15 Cushing, Irvine, CA, USA, 92618

Website

https://www.oncocyte.com

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.

OncoCyte (LTS:0KCC) Headlines

No Headlines